These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Use of thrombolytic therapy to treat heparin-refractory pulmonary embolism in a menstruating patient. Koch AZ; Abubaker J; Barnett VT; Chan LN Pharmacotherapy; 2002 Jan; 22(1):118-22. PubMed ID: 11794423 [TBL] [Abstract][Full Text] [Related]
28. Prehospital thrombolysis of a massive pulmonary embolus. Perkins ZB; Mitchell C; Donald O Emerg Med J; 2008 May; 25(5):303-4. PubMed ID: 18434474 [No Abstract] [Full Text] [Related]
29. Thrombolytic therapy for massive pulmonary embolism in a patient with a known intracranial tumor. Han S; Chaya C; Hoo GW J Intensive Care Med; 2006; 21(4):240-5. PubMed ID: 16855059 [TBL] [Abstract][Full Text] [Related]
30. Fibrinolysis for Acute Care of Pulmonary Embolism in the Intermediate Risk Patient. Meyer G; Planquette B; Sanchez O Curr Atheroscler Rep; 2015 Dec; 17(12):68. PubMed ID: 26486512 [TBL] [Abstract][Full Text] [Related]
31. Fibrinolysis in pulmonary embolism. Indication and results. Heinrich F Ann Radiol (Paris); 1980; 23(4):316-20. PubMed ID: 7387087 [No Abstract] [Full Text] [Related]
32. Effectiveness of low-dose prolonged infusion of tissue plasminogen activator in a nonagenarian patient with acute pulmonary embolism and main pulmonary artery thrombus. Yildiz M; Karakoyun S; Acar RD; Ozkan M Blood Coagul Fibrinolysis; 2013 Jan; 24(1):95-6. PubMed ID: 23037320 [TBL] [Abstract][Full Text] [Related]
33. [The PEITHO study: for a clarification of the indications for the fibrinolytic treatment of pulmonary embolism]. Meyer G Rev Pneumol Clin; 2008 Dec; 64(6):326-7. PubMed ID: 19084213 [No Abstract] [Full Text] [Related]
34. Impaired resolution of massive pulmonary embolism associated with an inhibited fibrinolytic response. Deitcher SR; Lucore CL; Eisenberg PR Am J Med; 1994 May; 96(5):483-4. PubMed ID: 8192182 [No Abstract] [Full Text] [Related]
35. Recombinant tissue plasminogen activator for both pulmonary and cerebral embolism. Yeguiayan JM; Benatru I; Guiu B; Taam JA; Albertini S; Freysz M; Giroud M Am J Emerg Med; 2011 Oct; 29(8):961.e1-4. PubMed ID: 21030188 [No Abstract] [Full Text] [Related]
36. Systemic fibrinolysis for acute pulmonary embolism complicating acute respiratory distress syndrome in severe COVID-19: a case series. Della Bona R; Valbusa A; La Malfa G; Giacobbe DR; Ameri P; Patroniti N; Robba C; Gilad V; Insorsi A; Bassetti M; Pelosi P; Porto I; Eur Heart J Cardiovasc Pharmacother; 2021 Jan; 7(1):78-80. PubMed ID: 32663257 [No Abstract] [Full Text] [Related]
37. [71-year-old patient with recurrent acute dyspnea]. Cuneo A; Aschenbrenner T; Boden B Dtsch Med Wochenschr; 2010 Apr; 135(17):857-8. PubMed ID: 20408104 [No Abstract] [Full Text] [Related]
38. Anticoagulants and thrombolysis in the treatment of pulmonary embolism. Raskob GE Curr Opin Pulm Med; 1995 Jul; 1(4):291-7. PubMed ID: 9363067 [TBL] [Abstract][Full Text] [Related]